| Heading: |
AstraZeneca: Merseyside |
| Question ID: |
1761069 |
| UIN: |
27974 |
| House: |
Commons |
| Date tabled: |
2025-02-03 |
| Asking Member ID: |
429 |
| Asking Member display name: |
Derek Twigg
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Derek Twigg
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Science, Innovation and Technology, which Departments were involved in discussions with Astra-Zeneca on the expansion of the vaccine production plant at Speke Merseyside. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-02-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4822 |
| Answering Member display name: |
Feryal Clark
|
| Answering Member handle: |
FeryalClark
|
| Answering Member Twitter reference: |
@FeryalClark
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
A cross-Government approach is taken to support the UK’s Life Sciences sector. This was the case for Government’s work to explore AstraZeneca’s potential investment in Speke, which involved No10, HM Treasury, the Department for Science, Innovation and Tec... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
216 |
| Answering body name: |
Department for Science, Innovation and Technology |
| Tweeted: |
true |